PET of αvbeta3-integrin and αvbeta5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy: ready for prime time?
- PMID: 21321266
- DOI: 10.2967/jnumed.110.078568
PET of αvbeta3-integrin and αvbeta5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy: ready for prime time?
Comment on
-
Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent.J Nucl Med. 2011 Mar;52(3):424-30. doi: 10.2967/jnumed.110.077479. Epub 2011 Feb 14. J Nucl Med. 2011. PMID: 21321268
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources